The study by Ikeda et al. showed no influence of 50 mg/day of the antiepileptic drug zonisamide on striatal DAT binding in a [123I]I-FP-CIT SPECT study in 15 PD patients [98]. The gene discussed is SLC6A3; the disease is Parkinson disease.